205 related articles for article (PubMed ID: 3891239)
1. Amcinonide vs. betamethasone dipropionate ointments in the treatment of psoriasis.
Huntley AC; Isseroff R
Cutis; 1985 May; 35(5):489-92. PubMed ID: 3891239
[TBL] [Abstract][Full Text] [Related]
2. Treatment of psoriasis with amcinonide 0.1 percent and fluocinonide 0.05 percent ointments. A comparative double-blind study.
Engel MF
Cutis; 1982 Jun; 29(6):646-50. PubMed ID: 7049592
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of amcinonide and halcinonide in the treatment of eczematous dermatitis.
Bickers DR
Cutis; 1984 Aug; 34(2):190-4. PubMed ID: 6383735
[TBL] [Abstract][Full Text] [Related]
4. Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.
Sharma SD
Indian J Dermatol; 1986; 31(2-3):34-7. PubMed ID: 3327820
[No Abstract] [Full Text] [Related]
5. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
Jacobson C; Cornell RC; Savin RC
Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
[TBL] [Abstract][Full Text] [Related]
6. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
[TBL] [Abstract][Full Text] [Related]
7. Comparison of amcinonide ointment 0.1 percent twice daily and fluocinonide ointment 0.05 percent three times daily in the treatment of psoriasis.
Cornell RC
Cutis; 1983 May; 31(5):566-9. PubMed ID: 6851655
[TBL] [Abstract][Full Text] [Related]
8. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.
van Dijk E; Bakkers EJ; Go MJ; Montnor LP; Roessel FE; van der Wateren AR; Wuite J
Cutis; 1983 Sep; 32(3):284-5, 287. PubMed ID: 6354613
[TBL] [Abstract][Full Text] [Related]
9. Betamethasone dipropionate cream for the treatment of psoriasis. A collaborative evaluation.
Charney P
Arch Dermatol; 1976 May; 112(5):681-3. PubMed ID: 776090
[TBL] [Abstract][Full Text] [Related]
10. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
Clark RF; Clement ER
Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
12. A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis.
Ellis CN; Katz HI; Rex IH; Shavin JS; Van Scott EJ; VanderPloeg D
Clin Ther; 1989; 11(6):768-74. PubMed ID: 2692821
[TBL] [Abstract][Full Text] [Related]
13. Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
Shupack JL; Jondreau L; Kenny C; Stiller MJ
Dermatology; 1993; 186(2):129-32. PubMed ID: 8428041
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
Molin L; Cutler TP; Helander I; Nyfors B; Downes N
Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
[TBL] [Abstract][Full Text] [Related]
15. Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.
Roberts DT
Cutis; 1996 Feb; 57(2 Suppl):27-31. PubMed ID: 8646866
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of amcinonide and halcinonide 0.1% ointments in the treatment of psoriasis.
Millikan LE; Mroczkowski TF
Int J Dermatol; 1986 Oct; 25(8):542. PubMed ID: 3533806
[No Abstract] [Full Text] [Related]
17. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
Mensing H; Korsukewitz G; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1149-52. PubMed ID: 1757606
[TBL] [Abstract][Full Text] [Related]
19. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
20. A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study.
Thaçi D; Ortonne JP; Chimenti S; Ghislain PD; Arenberger P; Kragballe K; Saurat JH; Khemis A; Sprøgel P; Esslinger HU; Unnebrink K; Kupper H
Br J Dermatol; 2010 Aug; 163(2):402-11. PubMed ID: 20377585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
